|1.||Theoharides, Theoharis C: 17 articles (02/2015 - 06/2003)|
|2.||Holsboer, F: 12 articles (11/2015 - 01/2000)|
|3.||Koob, George F: 11 articles (02/2012 - 12/2004)|
|4.||Taché, Yvette: 10 articles (01/2015 - 01/2002)|
|5.||Nemeroff, Charles B: 10 articles (01/2014 - 01/2002)|
|6.||Chrousos, George P: 9 articles (10/2012 - 02/2002)|
|7.||Chen, Alon: 8 articles (02/2016 - 01/2004)|
|8.||Du, Ji-Zeng: 8 articles (03/2015 - 07/2004)|
|9.||Million, Mulugeta: 8 articles (01/2015 - 01/2002)|
|10.||Holsboer, Florian: 8 articles (01/2013 - 01/2004)|
05/22/1986 - "We conclude that the pathophysiologic features of hypercortisolism in depression and Cushing's disease are distinct in each of the disorders and that the ovine corticotropin-releasing hormone stimulation test can be helpful in their differential diagnosis."
05/22/1986 - "The purpose of this study was to evaluate whether the pituitary-adrenal responses to ovine corticotropin-releasing hormone could help to clarify the mechanism of hypercortisolism in depression and in Cushing's disease and to assist in the differential diagnosis of these disorders. "
07/05/1984 - "These studies demonstrate that ectopic secretion of corticotropin-releasing factor is a cause of Cushing's syndrome in human beings. "
06/01/2010 - "3 Tesla magnetic resonance imaging with and without corticotropin releasing hormone stimulation for the detection of microadenomas in Cushing's syndrome."
01/01/2007 - "[The value of corticotropin-releasing hormone (CRH) test for differential diagnosis of Cushing's syndrome]."
|2.||Anxiety Disorders (Anxiety Disorder)
01/01/2009 - "The Sheehan Suicidality Tracking Scale was incorporated into a multicenter, randomized, double-blind, placebo-controlled, and active comparator study examining the efficacy of an experimental corticotropin-releasing factor antagonist (BMS-562086) for the treatment of generalized anxiety disorder. "
05/01/2010 - "Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder."
01/01/1993 - "The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies."
02/15/2012 - "Faulty regulation of the central extrahypothalamic corticotropin-releasing factor (CRF) expression is associated with stress-related psychopathologies including anxiety disorders and depression. "
06/01/2011 - "Corticotropin-releasing factor (CRF) functions as one of the major mediators of the mammalian stress response and appears to play a key role in the pathophysiology of mood and anxiety disorders. "
|3.||Bipolar Disorder (Mania)
11/01/2014 - "The aim of the present study was to investigate the relationship between peripheral levels of corticotropin-releasing hormone (CRH) and interleukin-1β (IL-1β) in individuals with bipolar disorder (BD) with and without suicide risk (SR), and controls. "
04/01/2014 - "Corticotropin-releasing factor (CRF) is implicated in the pathogenesis of bipolar disorder, an illness associated with deficits in prepulse inhibition (PPI) of the acoustic startle response. "
04/01/2005 - "We examined HPA axis function in a pilot study of five patients with rapid-cycling bipolar disorder in both relapse and remission using the dexamethasone/corticotropin releasing hormone (dex/CRH) test. "
11/01/2014 - "Immune dysfunction in bipolar disorder and suicide risk: is there an association between peripheral corticotropin-releasing hormone and interleukin-1β?"
07/01/1999 - "Enhanced corticotropin response to corticotropin-releasing hormone as a predictor of mania in euthymic bipolar patients."
03/17/2008 - "The contribution of corticotropin-releasing hormone (CRH) in the modulation of ischemia-induced cell death in vivo remains unclear. "
01/06/2006 - "Corticotropin-releasing hormone (CRH) has been implicated in ischemia-induced neurotoxicity, due in part to excitatory effects at the hippocampus, and the demonstrated neuroprotective effects of centrally administered, non-specific CRH antagonists. "
07/30/2004 - "The excitatory actions of corticotropin-releasing hormone (CRH) in the brain and the neuroprotective effects of CRH antagonists in models of ischemia suggest a role for this peptide in the cascade of events leading to cellular damage. "
01/01/2004 - "Detrimental role of corticotropin-releasing factor on the decrease of CA1 field potential induced by in vitro ischemia in rat hippocampal slices."
09/11/1995 - "Corticotropin-releasing hormone (CRH) antagonism has neuroprotective effects in models of ischemia. "
04/14/2010 - "Furthermore, pharmacologic inhibition (with a corticotropin-releasing factor 1 receptor antagonist) of pain-related hyperactivity in the basolateral amygdala (BLA), but not central amygdala (CeA), reversed deactivation of mPFC pyramidal cells and improved decision-making deficits. "
04/01/2006 - "This study examines the contribution of central corticotropin-releasing factor (CRF) to pain behavior. "
10/01/1999 - "Corticotropin-releasing-hormone lacks analgesic properties: an experimental study in humans, using non-inflammatory pain."
06/01/2015 - "As locus coeruleus has been involved in pain and stress-related patologies, we tested whether the pain-induced anxiety is a result of the corticotropin-releasing factor released in the locus coeruleus. "
06/01/2015 - "Corticotropin-Releasing Factor Mediates Pain-Induced Anxiety through the ERK1/2 Signaling Cascade in Locus Coeruleus Neurons."
|1.||Adrenocorticotropic Hormone (ACTH)
|5.||Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)
|7.||Neurotransmitter Agents (Neurotransmitter)
|9.||Interleukin-1 (Interleukin 1)